IRPSX
Price
$10.32
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Net Assets
284.89M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

IRPSX vs VVIAX

Header iconIRPSX vs VVIAX Comparison
Open Charts IRPSX vs VVIAXBanner chart's image
VY® T. Rowe Price Equity Income S
Price$10.32
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets284.89M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
IRPSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRPSX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRPSX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. IRPSX (285M). VVIAX pays higher dividends than IRPSX: VVIAX (2.18) vs IRPSX (1.61). IRPSX was incepted earlier than VVIAX: IRPSX (37 years) vs VVIAX (25 years). IRPSX (0.89) is less costly to investors than VVIAX (0.05). IRPSX is a more actively managed with annual turnover of: 21.00 vs. VVIAX (9.00). IRPSX has a lower initial minimum investment than VVIAX: IRPSX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. IRPSX (-2.84). VVIAX return over 5 years is better than : 68.54 vs. IRPSX (29.26).
IRPSXVVIAXIRPSX / VVIAX
Total Expense Ratio0.860.051,720%
Annual Report Gross Expense Ratio0.890.051,780%
Fund Existence37 years25 years-
Gain YTD-3.4486.517-53%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M196B0%
Annual Yield % from dividends1.612.1874%
Returns for 1 year-2.847.91-36%
Returns for 3 years1.3825.935%
Returns for 5 years29.2668.5443%
Returns for 10 years-8.88114.61-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp